Ronaghi Mostafa has filed 4 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 35000 shares of Summit Therapeutics Inc. ($SMMT) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Summit Therapeutics Inc. | $SMMT | Ronaghi Mostafa | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 744,442,538 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Summit Therapeutics Inc. | $SMMT | Ronaghi Mostafa | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| April 11, 2024 | Summit Therapeutics Inc. | $SMMT | Ronaghi Mostafa | Director | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| April 11, 2024 | Summit Therapeutics Inc. | $SMMT | Ronaghi Mostafa | Director | A | Stock Option (right to buy) | 25315 | $0.00 | 225,315.0000 | 0 | 12.66% | 0.00% |